The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is the randomized blind research of the assessment of the different
levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass
(CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during
cardiac surgery, the investigators would like to know if the glycemia levels in clondine
group will be lower than placebo group.